Mary Tagliaferri

Mary Tagliaferri

Directeur Technique/Scientifique/R&D chez NEKTAR THERAPEUTICS
60 ans
Health Technology
Consumer Services
Finance

Profil

Mary A. Tagliaferri was the founder of Bionovo, Inc., founded in 2002, where the titles held included President, Secretary, Treasurer & Director from 2011 to 2012.
Current jobs include Director at Iambic Therapeutics, Inc. starting in 2024 and Chief Medical Officer at Nektar Therapeutics starting in 2025.
Former jobs include Director at Atossa Therapeutics, Inc., Independent Director at Rayzebio, Inc. from 2021 to 2024, Independent Director at Enzo Biochem, Inc. from 2023 to 2024, Independent Director at Y-mAbs Therapeutics, Inc. from 2024 to 2025, Secretary, Treasurer & Chief Regulatory Officer at Lighten Up Enterprises International, Inc., and Chief Medical Officer at Kanglaite USA, Inc. from 2012 to 2014.
Education includes an undergraduate degree from Cornell University in 1988, a graduate degree from American College of Traditional Chinese Medicine in 1995, and a doctorate from The University of California, San Francisco in 2002.

Postes actifs de Mary Tagliaferri

SociétésPosteDébut
NEKTAR THERAPEUTICS Directeur Technique/Scientifique/R&D 01/09/2025
Directeur/Membre du Conseil 19/09/2024

Anciens postes connus de Mary Tagliaferri

SociétésPosteFin
YMAS THER Directeur/Membre du Conseil 11/07/2025
ENZO BIOCHEM, INC. Président 25/10/2023
RAYZEBIO, INC. Directeur/Membre du Conseil 26/02/2024
Directeur Technique/Scientifique/R&D 01/06/2014
BIONOVO INC. Fondateur 01/06/2012
Voir l'expérience en détail de Mary Tagliaferri

Formation de Mary Tagliaferri

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

86

Relations au 1er degré

12

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées12

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Technology Services

  1. Bourse
  2. Insiders
  3. Mary Tagliaferri
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇